Skip to content

Fighting fatigue! An intervention to reduce fatigue.

More independent and less tired: the development, execution and evaluation of a psychosocial intervention for renal patients on dialysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22752
Enrollment
74
Registered
2015-08-17
Start date
2015-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease, Dialysis, Fatigue

Interventions

Psychosocial counseling (intervention group) VS regular treatment without psychosocial counseling (control group). The psychosocial intervention consists of 4-6 individual sessions with a medical soci

Sponsors

VUmc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Kidney patients (M / F) who: - Undergo daytime dialysis (PD, HD, both at home and in the hospital or dialysis center); - Experience (severe) fatigue; - Are 18 years or older; - Are in the ability of physical activity (walk at least 10 minutes with or without supporting device such as a walking stick); - Are sufficient in Dutch language in order to participate in (group)interviews and to fill out Dutch questionnaires.

Exclusion criteria

Exclusion criteria: Patients can not participate in the study under circumstances of: - Participation in other research or treatment aimed at reducing fatigue; - Treatment by a psychologist or psychiatrist (for severe psychiatric problems such as depression, psychosis, personality disorders or schizophrenia); - Alcohol or drug addiction.

Design outcomes

Primary

MeasureTime frame
Fatigue severity, measured by a sub-scale of the CIS-fatigue.

Secondary

MeasureTime frame
Quality of Life (kidney disease specific) as measured by the KDQOL. Questionnaires on coping style (CERQ), illness cognitions/perceptions (ZCL + IPQ-R), catastrophising thoughts (J-FCS), depression (PHQ-9) and overall perceptions of mastery and control (Mastery-scale)are included since these outcomes may be potential moderating or mediating factors. In addition, various medical parameters and demographics will be studied as potential modifiers.

Contacts

Public ContactW.E. van der Borg

VUmc, afdeling Metamedica

E: w.vanderborg@vumc.nlT: 020 4448218

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)